NEVRO CORP. Business Combination, Consideration Transferred, Liabilities Incurred
NEVRO CORP. reported Business Combination, Consideration Transferred, Liabilities Incurred of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes
us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred · last filed 2025-03-04
- NEVRO CORP. business combination, consideration transferred, liabilities incurred for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- NEVRO CORP. business combination, consideration transferred, liabilities incurred for fiscal 2023 was $22.09M.
- NEVRO CORP. business combination, consideration transferred, liabilities incurred for fiscal 2022 was $0.00.
| Period end | Business Combination, Consideration Transferred, Liabilities Incurred 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-04 |
| 2023-12-31 | $22.09M 10-K · filed 2025-03-04 |
| 2022-12-31 | $0.00 10-K · filed 2025-03-04 |